Willingness, decision-making factors, and anticipated impacts of alzheimer’s dementia risk estimation: a cross-national online survey in Germany, Spain, and Switzerland

Abstract Background As blood-based biomarker tests for Alzheimer’s dementia risk estimation approach clinical and direct-to-consumer availability, understanding public attitudes and anticipated impacts of risk disclosure is critical for ethical implementation. However, cross-national evidence on willingness, decision-making factors, and anticipated psychological impacts among European general populations remains scarce. Methods We conducted a cross-national online survey, quota-sampled by age and gender, among adults in Germany, Spain, and Switzerland ( N = 2,750), assessing willingness to learn one’s risk for Alzheimer’s dementia, testing preferences, decision-making factors, and anticipated impacts of a hypothetical high-risk result. Multivariable regression analyses examined sociodemographic, cognitive, and psychosocial predictors of willingness and anticipated impacts. Results Overall, 72% of respondents expressed willingness to know their risk, with the highest proportion in Spain (76.8%), and a preference for blood-based testing (69%). Regression analyses identified younger age, having a relative or friend affected, self-reported memory problems, greater subjective knowledge about dementia, higher age-related risk perception, and greater objective numeracy as statistically significant but modest predictors of willingness (all p < .001; adj. R² = 0.04). The most influential decision-making factors were the availability of preventive or therapeutic options and a family history of dementia. Across countries, many participants viewed risk knowledge as an opportunity for future planning, while impacts on self-image and psychological burden (e.g., anxiety or depression) were also anticipated. Anticipated psychological burden was most pronounced among those with lower resilience ( β = − 0.40, p < .001, adj. R² = 0.19). Conclusion Interest in Alzheimer’s dementia risk estimation appears high, while motives and anticipated impacts are diverse. The limited explained variance across outcome domains and the weak predictive value of identified factors underscore the difficulty of anticipating individual responses and highlight the need for public health strategies that move beyond uniform approaches. Person-centered, ethically grounded counseling that accommodates diverse motivations and individual vulnerability profiles is essential to support autonomous decision-making, particularly as risk estimation becomes accessible through clinical services such as Brain Health Services and direct-to consumer-settings.

Authors

Institutions

Publication Details

Journal
BMC Public Health
Published
2026-11-14
DOI
https://doi.org/10.1186/s12889-026-30374-0
Primary Topic
Dementia and Cognitive Impairment Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Willingness, decision-making factors, and anticipated impacts of alzheimer’s dementia risk estimation: a cross-national online survey in Germany, Spain, and Switzerland

Constanze Hübner, Ayda Rostamzadeh, Michelle Gerards, Christiane Woopen et al.
BMC Public Health
Dementia and Cognitive Impairment Research
article

Willingness, decision-making factors, and anticipated impacts of alzheimer’s dementia risk estimation: a cross-national online survey in Germany, Spain, and Switzerland

Constanze Hübner, Ayda Rostamzadeh, Michelle Gerards, Christiane Woopen, Yahveth Cantero‐Fortiz, Merçé Boada, Giovanni Battista Frisoni, Frank Jessen, Annika Baumeister, Carolin Schwegler, Federica Ribaldi, Björn Schmitz‐Luhn, J Braun, J Zoll
article en

Abstract

Abstract Background As blood-based biomarker tests for Alzheimer’s dementia risk estimation approach clinical and direct-to-consumer availability, understanding public attitudes and anticipated impacts of risk disclosure is critical for ethical implementation. However, cross-national evidence on willingness, decision-making factors, and anticipated psychological impacts among European general populations remains scarce. Methods We conducted a cross-national online survey, quota-sampled by age and gender, among adults in Germany, Spain, and Switzerland ( N = 2,750), assessing willingness to learn one’s risk for Alzheimer’s dementia, testing preferences, decision-making factors, and anticipated impacts of a hypothetical high-risk result. Multivariable regression analyses examined sociodemographic, cognitive, and psychosocial predictors of willingness and anticipated impacts. Results Overall, 72% of respondents expressed willingness to know their risk, with the highest proportion in Spain (76.8%), and a preference for blood-based testing (69%). Regression analyses identified younger age, having a relative or friend affected, self-reported memory problems, greater subjective knowledge about dementia, higher age-related risk perception, and greater objective numeracy as statistically significant but modest predictors of willingness (all p < .001; adj. R² = 0.04). The most influential decision-making factors were the availability of preventive or therapeutic options and a family history of dementia. Across countries, many participants viewed risk knowledge as an opportunity for future planning, while impacts on self-image and psychological burden (e.g., anxiety or depression) were also anticipated. Anticipated psychological burden was most pronounced among those with lower resilience ( β = − 0.40, p < .001, adj. R² = 0.19). Conclusion Interest in Alzheimer’s dementia risk estimation appears high, while motives and anticipated impacts are diverse. The limited explained variance across outcome domains and the weak predictive value of identified factors underscore the difficulty of anticipating individual responses and highlight the need for public health strategies that move beyond uniform approaches. Person-centered, ethically grounded counseling that accommodates diverse motivations and individual vulnerability profiles is essential to support autonomous decision-making, particularly as risk estimation becomes accessible through clinical services such as Brain Health Services and direct-to consumer-settings.

BMC Public Health
University of Geneva (CH), University of Bonn (DE), University of Cologne (DE), Instituto de Salud Carlos III (ES), German Center for Neurodegenerative Diseases (DE), Universitat Internacional de Catalunya (ES), Biomedical Research Networking Center on Neurodegenerative Diseases (ES), University Hospital of Geneva (CH), Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (DE)
Dementia and Cognitive Impairment Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon